Endoscopic Sclerotherapy and/or Ligation Versus Portacaval Shunt for Bleeding Gastric Varices

NCT00820781 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 518

Last updated 2009-01-12

No results posted yet for this study

Summary

In unselected cirrhotic patients with bleeding gastric varices to compare the influence on mortality rate, duration of life, control of bleeding, quality of life, and economic costs of treatment of: portacaval shunt, endoscopic variceal sclerotherapy and/or variceal ligation.

Conditions

  • Gastric Bleeding
  • Cirrhosis

Interventions

PROCEDURE

Portacaval shunt

Subject taken to the operating room and undergoes portacaval shunt surgery

PROCEDURE

Sclerotherapy

Subject taken to Endoscopy Suite and undergoes endoscopic sclerotherapy

Sponsors & Collaborators

Principal Investigators

  • Marshall J Orloff, M.D. · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1977-08-31
Primary Completion
1977-12-31
Completion
2003-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00820781 on ClinicalTrials.gov